CocrystalPharmaInc.jpg
Cocrystal Pharma Presents Data at the 26th International Symposium on Hepatitis C Virus and Related Viruses
08. Oktober 2019 09:15 ET | Cocrystal Pharma, Inc.
- Novel class of HCV antivirals targeting the NS3 helicase that can be studied for the treatment of chronic HCV infection developed utilizing Company’s unique structure-based drug design platform...